VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Prod...

FDA Device Recall #Z-0445-2019 — Class II — September 14, 2018

Recall Summary

Recall Number Z-0445-2019
Classification Class II — Moderate risk
Date Initiated September 14, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Luminex Corporation
Location Austin, TX
Product Type Devices
Quantity 12,700 trays

Product Description

VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.

Reason for Recall

Potential to lead to a false negative results.

Distribution Pattern

Worldwide Distribution - US Nationwide in the states of United States - AZ, CA, CO, CT, DC, FL, GA,, IA, ID, IN, KA,, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NV, NJ, NY, OK,,OH, OR, PA, SC, TN, TX, UT, VT, WA, KS, and VA.. France

Lot / Code Information

Supplier raw tray lots 195916-070518 and 190943-073118 Utility Tray Lots: 082518018C, 081618018C, 082918018C, 090418018B, 081118018C and 082718018B

Other Recalls from Luminex Corporation

Recall # Classification Product Date
Z-1903-2025 Class II VERIGENE Gram Negative Blood Culture (BC-GN) Nu... Apr 16, 2025
Z-2533-2024 Class II Verigene Gram Positive Blood Culture (BC-GP) Nu... Jun 20, 2024
Z-0500-2024 Class II Luminex VERIGENE BC-GP Utility Tray (5-Pack Car... Nov 7, 2023
Z-2023-2023 Class II Verigene Enteric Pathogens Nucleic Acid Test (E... Jun 5, 2023
Z-2024-2023 Class II VERIGENE Clostridium difficile Nucleic Acid Tes... Jun 5, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.